These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25344064)

  • 1. Dantrolene for cerebral vasospasm after subarachnoid haemorrhage: a randomised double blind placebo-controlled safety trial.
    Muehlschlegel S; Carandang R; Hall W; Kini N; Izzy S; Garland B; Ouillette C; van der Bom IM; Flood TF; Gounis MJ; Weaver JP; Barton B; Wakhloo AK
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1029-35. PubMed ID: 25344064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a single dose of dantrolene in patients with cerebral vasospasm after subarachnoid hemorrhage: a prospective pilot study.
    Muehlschlegel S; Rordorf G; Sims J
    Stroke; 2011 May; 42(5):1301-6. PubMed ID: 21454813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: a cohort study.
    Chalouhi N; Daou B; Okabe T; Starke RM; Dalyai R; Bovenzi CD; Anderson EC; Barros G; Reese A; Jabbour P; Tjoumakaris S; Rosenwasser R; Kraft WK; Rincon F
    J Neurosurg; 2016 Sep; 125(3):730-6. PubMed ID: 26799296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients.
    Fujimura M; Joo JY; Kim JS; Hatta M; Yokoyama Y; Tominaga T
    Cerebrovasc Dis; 2017; 44(1-2):59-67. PubMed ID: 28463833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).
    Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Bach D; Frey A; Marr A; Roux S; Kassell N
    Lancet Neurol; 2011 Jul; 10(7):618-25. PubMed ID: 21640651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
    Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
    Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
    Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
    J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
    Macdonald RL; Kassell NF; Mayer S; Ruefenacht D; Schmiedek P; Weidauer S; Frey A; Roux S; Pasqualin A;
    Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between hyponatraemia and long-term functional outcome in patients with aneurysmal subarachnoid haemorrhage: A single centre prospective cohort study.
    Quinn L; Tian DH; Fitzgerald E; Flower O; Andersen C; Hammond N; Davidson K; Delaney A
    J Clin Neurosci; 2020 Aug; 78():353-359. PubMed ID: 32622650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.
    Vajkoczy P; Meyer B; Weidauer S; Raabe A; Thome C; Ringel F; Breu V; Schmiedek P
    J Neurosurg; 2005 Jul; 103(1):9-17. PubMed ID: 16121967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article.
    Tseng MY; Hutchinson PJ; Richards HK; Czosnyka M; Pickard JD; Erber WN; Brown S; Kirkpatrick PJ
    J Neurosurg; 2009 Jul; 111(1):171-80. PubMed ID: 19344224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dantrolene mediates vasorelaxation in cerebral vasoconstriction: a case series.
    Muehlschlegel S; Rordorf G; Bodock M; Sims JR
    Neurocrit Care; 2009; 10(1):116-21. PubMed ID: 18696267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.
    Lynch JR; Wang H; McGirt MJ; Floyd J; Friedman AH; Coon AL; Blessing R; Alexander MJ; Graffagnino C; Warner DS; Laskowitz DT
    Stroke; 2005 Sep; 36(9):2024-6. PubMed ID: 16051891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.
    Gathier CS; van den Bergh WM; Slooter AJ;
    Int J Stroke; 2014 Apr; 9(3):375-80. PubMed ID: 23692645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial dantrolene for refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Majidi S; Grigoryan M; Tekle WG; Qureshi AI
    Neurocrit Care; 2012 Oct; 17(2):245-9. PubMed ID: 22815125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Parenteral Dantrolene in the Contemporary Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review.
    Ortiz M; Nunna RS; Ravipati K; Tran A; Qureshi AI; Siddiq F
    World Neurosurg; 2022 May; 161():e602-e607. PubMed ID: 35189422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased Flow Velocity with Transcranial Color-Coded Duplex Sonography Correlates with Delayed Cerebral Ischemia due to Peripheral Vasospasm of the Middle Cerebral Artery.
    Sadahiro H; Shirao S; Yoneda H; Ishihara H; Oku T; Inamura A; Yamane A; Sugimoto K; Fujiyama Y; Suzuki M
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2352-9. PubMed ID: 27544866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of intraventricular sodium nitroprusside in vasospasm secondary to aneurysmal subarachnoid haemorrhage: a 5-year prospective study with review of the literature.
    Agrawal A; Patir R; Kato Y; Chopra S; Sano H; Kanno T
    Minim Invasive Neurosurg; 2009 Feb; 52(1):5-8. PubMed ID: 19247898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.
    Shaw MD; Vermeulen M; Murray GD; Pickard JD; Bell BA; Teasdale GM
    J Neurosurg; 2000 Dec; 93(6):992-7. PubMed ID: 11117873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial of induced hypermagnesaemia following aneurysmal subarachnoid haemorrhage.
    Bradford CM; Finfer S; O'Connor A; Yarad E; Firth R; McCallister R; Harrington T; Steinfort B; Faulder K; Assaad N; Morgan M
    Crit Care Resusc; 2013 Jun; 15(2):119-25. PubMed ID: 23931043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.